BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30191285)

  • 1. Comparison of relative and absolute rectal dose-volume parameters and clinical correlation with acute and late radiation proctitis in prostate cancer patients.
    Paleny R; Bremer M; Walacides D; Mainwaring S; Weber K; Henkenberens C
    Strahlenther Onkol; 2019 Feb; 195(2):103-112. PubMed ID: 30191285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between acute histopathological changes of rectal walls and late radiation proctitis following radiotherapy for prostate cancer.
    Campostrini F; Remo A; Astati L; Zorzi M; Capodaglio G; Buffoli A; Moretti G; Della Monica B; Zanella C; Verlato G
    Strahlenther Onkol; 2020 Jul; 196(7):617-627. PubMed ID: 32166451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early and late toxicity profiles of patients receiving immediate postoperative radiotherapy versus salvage radiotherapy for prostate cancer after prostatectomy.
    Vogel MME; Kessel KA; Gschwend JE; Weichert W; Wilkens JJ; Combs SE
    Strahlenther Onkol; 2019 Feb; 195(2):131-144. PubMed ID: 30182246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy.
    Feng M; Hanlon AL; Pisansky TM; Kuban D; Catton CN; Michalski JM; Zelefsky MJ; Kupelian PA; Pollack A; Kestin LL; Valicenti RK; DeWeese TL; Sandler HM
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1417-23. PubMed ID: 17418972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of endoscopic evaluation for radiation proctitis in patients receiving intermediate-dose postoperative radiotherapy for rectal cancer.
    Lee J; Han HJ; Min BS; Hong SP; Shin SJ; Yoon HI; Park SJ; Koom WS
    Jpn J Clin Oncol; 2018 Nov; 48(11):988-994. PubMed ID: 30239826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: absolute or relative rectal volume?
    Kupelian PA; Reddy CA; Carlson TP; Willoughby TR
    Cancer J; 2002; 8(1):62-6. PubMed ID: 11895204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.
    Deville C; Vapiwala N; Hwang WT; Lin H; Ad VB; Tochner Z; Both S
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1389-96. PubMed ID: 21664069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.
    Goenka A; Magsanoc JM; Pei X; Schechter M; Kollmeier M; Cox B; Scardino PT; Eastham JA; Zelefsky MJ
    Eur Urol; 2011 Dec; 60(6):1142-8. PubMed ID: 21855208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity.
    Pederson AW; Fricano J; Correa D; Pelizzari CA; Liauw SL
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):235-41. PubMed ID: 21163587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter?
    Hsu CC; Paciorek AT; Cooperberg MR; Roach M; Hsu IC; Carroll PR
    BJU Int; 2015 Nov; 116(5):713-20. PubMed ID: 25600860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage radiotherapy for prostate cancer recurrence after cryosurgical ablation.
    Burton S; Brown DM; Colonias A; Cohen J; Miller R; Rooker G; Benoit R; Merlotti L; Quinn A; Kalnicki S
    Urology; 2000 Nov; 56(5):833-8. PubMed ID: 11068312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer.
    Peeters ST; Hoogeman MS; Heemsbergen WD; Slot A; Tabak H; Koper PC; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1142-52. PubMed ID: 15939547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved outcomes with higher doses for salvage radiotherapy after prostatectomy.
    King CR; Spiotto MT
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):23-7. PubMed ID: 18207668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
    Nitsche M; Brannath W; Brückner M; Wagner D; Kaltenborn A; Temme N; Hermann RM
    Br J Radiol; 2017 Feb; 90(1070):20160370. PubMed ID: 27936891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily sodium butyrate enema for the prevention of radiation proctitis in prostate cancer patients undergoing radical radiation therapy: results of a multicenter randomized placebo-controlled dose-finding phase 2 study.
    Maggio A; Magli A; Rancati T; Fiorino C; Valvo F; Fellin G; Ricardi U; Munoz F; Cosentino D; Cazzaniga LF; Valdagni R; Vavassori V
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):518-24. PubMed ID: 24803033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of changing rectal dose volume parameters over time on late rectal and urinary toxicity after high-dose intensity-modulated radiotherapy for prostate cancer: A 10-years single centre experience.
    Fonteyne V; Sadeghi S; Ost P; Vanpachtenbeke F; Vuye P; Lumen N; De Meerleer G
    Acta Oncol; 2015 Jun; 54(6):854-61. PubMed ID: 25387271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
    Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z
    Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes.
    Chen CP; Weinberg V; Shinohara K; Roach M; Nash M; Gottschalk A; Chang AJ; Hsu IC
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):324-9. PubMed ID: 23474112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors.
    Wachter S; Gerstner N; Goldner G; Pötzi R; Wambersie A; Pötter R
    Radiother Oncol; 2001 Apr; 59(1):65-70. PubMed ID: 11295208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.